Form 4 for ANTX AN2 Therapeutics, Inc.
Accepted 2024-01-19 00:00:00 ET · period of report 2024-01-18 · accession 0000950170-24-005900 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2024-01-19 | 2024-01-18 | ANTX | Zakrzewski Joseph S | Dir | S - Sale | $19.11 | -100.0K | 405.9K | -20% | -$1.91M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-01-18 | S | D | 100,000 | $19.11 | 405,880 | I See footnote | — | — | (F1) These shares are held by Z3 Trust, for which the Reporting Person is a trustee. |